|Articles|February 7, 2008
Merial drug adds claims
Previcox controls pain and inflammation.
Advertisement
Advertisement
Merial announced that the company has received FDA approval to expand the label claim for Previcox, a canine osteoarthritis pain reliever. The expanded label claim includes the control of postoperative pain and inflammation associated with soft-tissue surgery in dogs. For more, visit previcox.com.
Newsletter
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on dvm360
1
Clinic center: New Chewy Vet Care clinic features viewing treatment window
2
Long-acting therapy for relieving OA pain in cats receives European marketing authorization
3
Canadian dog treats recalled due to Salmonella contamination
4
Akston launches clinical trial for novel canine cancer therapy
5
